Medication pricing is determined by manufacturers and pharmacies, not the telehealth platform
Bradley, R., Fitzpatrick, A.L., Jenny, N.S., Lee, D.-H
Most patients reach their therapeutic dose between weeks 12 and 20, though some benefit from slower escalation based on individual tolerability
Diabetes Metab Res Rev 32:776790 Rosenstock J, Reusch J, Bush M et al (2009) Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing